Sun Pharma gets notice on drug pricing in US
The US Department of Justice's antitrust division has issued a subpoena to Mumbai-based Sun Pharma seeking information about the pricing and marketing of the generic drugs it sells in the US, the company said on Saturday. Reportedly, this comes amid a wider probe by US regulators into steep increases in the prices of generic drugs in recent years.